Skip to content

Understanding Your Medical Test: A Complete Patient Guide

Published: August 9, 2026Updated: August 16, 2026

This test checks for IgG antibodies against Borrelia burgdorferi (the bacterium that causes Lyme disease) in joint fluid using an immunoblot method.

Quick summary

{"Detects IgG antibodies to the 21kD protein of Borrelia burgdorferi in joint fluid","Helps confirm Lyme disease when joint involvement is suspected","Performed using immunoblot (Western blot) technique for high specificity","Positive results indicate exposure to Lyme disease bacteria","Results should be interpreted alongside clinical symptoms and other test results"}

Medically reviewed by WellAlly Editorial TeamLast reviewed August 16, 2026Editorial policy

Key facts at a glance

LOINC
30014-5
Short code
BB21IGGSF
Synonyms
B burgdor21kD IgG Snv Ql IB
Category
chemistry
Sample
fluid
Container
Sterile, leak-proof, screw-cap container without anticoagulants; cryovial preferred for immunoblot testing
Units
N/A
Fasting
false
Population
adult
Sex
all
Age range
18–65 years
Method
Immunoblot (Western Blot)
CPT
86617
SNOMED
39513008
Specimen volume
1-2 mL of synovial fluid
Stability
Refrigerated at 2-8°C: 7 days; Frozen at -20°C or below: 30 days; Avoid repeated freeze-thaw cycles
Hemolysis max
300
TAT
48–168 hours
Order
routine

This test is a laboratory procedure that helps your healthcare provider learn how your body is functioning. It measures specific substances in a sample taken from your body, giving your care team objective information that cannot be obtained from a physical exam or your medical history alone.

This test detects IgG (immunoglobulin G) antibodies specifically targeting the 21kD protein of Borrelia burgdorferi, the bacterium that causes Lyme disease. The test is performed on synovial fluid, which is the fluid that lubricates joints. By using an immunoblot (also known as Western blot) technique, the test can identify whether your immune system has produced specific antibodies against this particular bacterial protein.

Your doctor may order this test to look for signs of illness, confirm or rule out a suspected diagnosis, monitor a condition you already have, or check how well a treatment is working. It can also be part of a routine checkup or screening to catch potential problems early, before symptoms appear.

This test is primarily ordered when a patient has symptoms suggesting Lyme disease involvement in the joints, such as joint swelling, pain, or stiffness—particularly in the knees, though other joints may be affected. It helps healthcare providers confirm whether the joint symptoms are related to Lyme disease infection. The 21kD protein is one of the specific markers used in Lyme disease testing to ensure accuracy.

The test is usually done by collecting a small sample, most often blood drawn from a vein in your arm or sometimes urine or another specimen. A trained healthcare professional will clean the area, collect the sample, and send it to a laboratory for analysis. The procedure typically takes only a few minutes, and you can usually return to your normal activities right afterward.

A healthcare provider will collect a sample of synovial fluid from the affected joint using a needle and syringe in a procedure called arthrocentesis. This fluid is then sent to a laboratory where it is tested using the immunoblot technique. This method separates the bacterial proteins by size and detects whether IgG antibodies against the 21kD protein are present.

Your results show whether your measurements fall within the normal reference range for someone of your age and sex. Results within the normal range generally suggest no evidence of the condition being tested for, while results outside that range may point to a condition that needs further evaluation. Abnormal results do not always mean something serious, so your healthcare provider will interpret them together with your symptoms, history, and other tests before recommending next steps.

A positive result indicates that IgG antibodies against the Borrelia burgdorferi 21kD protein were detected in your synovial fluid. This suggests your immune system has been exposed to the Lyme disease bacterium and has produced an antibody response. A negative result means no antibodies against this specific protein were detected, though it does not completely rule out Lyme disease—especially if the infection is very recent. Your healthcare provider will interpret these results together with your symptoms, medical history, and other test findings.

Reference range

Negative: No IgG antibodies detected to Borrelia burgdorferi 21kD antigen. Positive: IgG antibodies detected to the 21kD antigen band.N/A

Specimen: fluid

No special patient preparation required. Synovial fluid collection requires arthrocentesis performed by a qualified healthcare provider under aseptic technique. Inform the patient of procedural risks including infection, bleeding, and joint discomfort.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

This test is significant for diagnosing Lyme disease arthritis, a manifestation of late Lyme disease that affects the joints. Detection of IgG antibodies in synovial fluid provides strong evidence that the joint symptoms are due to Borrelia burgdorferi infection rather than other forms of arthritis. The immunoblot method offers high specificity, reducing the chance of false-positive results. Positive results support the diagnosis and guide appropriate treatment, typically with antibiotics. This test is particularly valuable when blood test results are ambiguous or when joint symptoms persist despite treatment.

Frequently asked questions

Is joint fluid the same as blood? Can this test be done on blood instead?
No, this test is specifically performed on synovial (joint) fluid, not blood. While blood tests for Lyme disease exist, testing the joint fluid provides more direct evidence of joint involvement. Your healthcare provider will determine which tests are appropriate based on your symptoms.
Does a positive result mean I definitely have Lyme disease?
A positive result is a strong indicator of Lyme disease involvement in the joint, but your healthcare provider will consider your complete clinical picture—including symptoms, exposure history (such as tick bites), and other test results—to confirm the diagnosis.
What happens if the test is negative?
A negative result does not completely rule out Lyme disease. It could mean the infection is too early for antibodies to develop, or the infection may not be in the joints. Your healthcare provider may recommend additional testing or repeat testing at a later time if Lyme disease is still suspected.
Does this test require special preparation?
No special fasting or preparation is typically required. However, you should inform your healthcare provider about any medications you are taking. The main preparation is the joint fluid collection procedure, which may require avoiding certain joint movements before the test.
How long does it take to get results?
Immunoblot tests are more complex than standard blood tests and typically take several days to a week to complete. The laboratory will send results to your healthcare provider, who will discuss them with you.
  1. 1
  2. 2
  3. 3

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy